"Premature luteinization" in the era of GnRH analogue protocols: time to reconsider.
作者信息
Younis Johnny S
机构信息
Reproductive Medicine Unit, Department of Obstetrics & Gynecology, Poriya Medical Center, Tiberias, 15208, Israel.
出版信息
J Assist Reprod Genet. 2011 Aug;28(8):689-92. doi: 10.1007/s10815-011-9585-x. Epub 2011 May 26.
Abstract
摘要
相似文献
1
"Premature luteinization" in the era of GnRH analogue protocols: time to reconsider.
J Assist Reprod Genet. 2011 Aug;28(8):689-92. doi: 10.1007/s10815-011-9585-x. Epub 2011 May 26.
2
The treatment of patients with polycystic ovaries undergoing IVF.
J Assist Reprod Genet. 1997 Jan;14(1):12-4. doi: 10.1007/BF02765744.
3
Treatment of polycystic ovary patients undergoing IVF.
J Assist Reprod Genet. 1997 Jan;14(1):10-2. doi: 10.1007/BF02765743.
4
High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization.
Hum Reprod. 1998 Mar;13(3):573-5. doi: 10.1093/humrep/13.3.573.
5
A new approach to the management of patients at risk of ovarian hyperstimulation in an in-vitro fertilization programme.
Hum Reprod. 1991 Sep;6(8):1088-91. doi: 10.1093/oxfordjournals.humrep.a137489.
6
Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication.
Hum Reprod. 2000 Sep;15(9):1965-8. doi: 10.1093/humrep/15.9.1965.
7
Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment.
Hum Reprod. 2005 Nov;20(11):3192-7. doi: 10.1093/humrep/dei210. Epub 2005 Jul 21.
8
Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome.
Fertil Steril. 2003 Dec;80(6):1444-9. doi: 10.1016/j.fertnstert.2003.07.002.
9
Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome.
Fertil Steril. 2004 Jan;81(1):1-5. doi: 10.1016/j.fertnstert.2003.05.032.
10
[How to prevent completely ovarian hyperstimulation with GnRH-based stimulation protocols].
Akush Ginekol (Sofiia). 2001;40(4):36-41.
引用本文的文献
1
The curious case of premature luteinization.
J Assist Reprod Genet. 2018 Oct;35(10):1723-1740. doi: 10.1007/s10815-018-1264-8. Epub 2018 Jul 26.
2
Adverse effect of prematurely elevated progesterone in in vitro fertilization cycles: a literature review.
Biol Reprod. 2018 Jul 1;99(1):45-51. doi: 10.1093/biolre/ioy082.
3
Are extremely high progesterone levels still an issue in IVF?
J Endocrinol Invest. 2017 Jan;40(1):69-75. doi: 10.1007/s40618-016-0531-8. Epub 2016 Aug 27.
4
Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger?
Fertil Steril. 2016 Sep 1;106(3):584-589.e1. doi: 10.1016/j.fertnstert.2016.04.024. Epub 2016 May 10.
5
Premature progesterone rise at human chorionic gonadotropin triggering day has no correlation with intracytoplasmic sperm injection outcome.
Iran J Reprod Med. 2015 Feb;13(2):79-84.
6
Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation?
Fertil Steril. 2015 Jun;103(6):1477-84.e1-5. doi: 10.1016/j.fertnstert.2015.02.038. Epub 2015 Apr 14.
本文引用的文献
1
Elevated P level on the day of hCG administration is related to FSH dose: is it the whole truth?
Hum Reprod. 2011 Feb;26(2):498-9; author reply 499-500. doi: 10.1093/humrep/deq355. Epub 2010 Dec 15.
2
The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles.
Reprod Biomed Online. 2010 Oct;21(4):446-9. doi: 10.1016/j.rbmo.2010.05.018. Epub 2010 Jun 16.
3
Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles.
Hum Reprod. 2010 Aug;25(8):2092-100. doi: 10.1093/humrep/deq125. Epub 2010 Jun 10.
4
Pre-hCG elevation of plasma progesterone: good, bad or otherwise.
Hum Reprod Update. 2008 Jul-Aug;14(4):393. doi: 10.1093/humupd/dmn020. Epub 2008 Jun 2.
5
Progesterone elevation on the day of hCG: methodological issues.
Hum Reprod Update. 2008 Jul-Aug;14(4):391-2. doi: 10.1093/humupd/dmn019. Epub 2008 Jun 2.
6
Comment on: is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. By Venetis et al (2007).
Hum Reprod Update. 2008 Mar-Apr;14(2):194-5; author reply 195-6. doi: 10.1093/humupd/dmm046. Epub 2008 Jan 28.
7
Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis.
Hum Reprod Update. 2007 Jul-Aug;13(4):343-55. doi: 10.1093/humupd/dmm007. Epub 2007 Apr 3.
8
Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.
Hum Reprod. 2006 Dec;21(12):3217-27. doi: 10.1093/humrep/del284. Epub 2006 Jul 27.
9
Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome.
Fertil Steril. 2003 Dec;80(6):1444-9. doi: 10.1016/j.fertnstert.2003.07.002.
10
Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone.
Fertil Steril. 2003 Aug;80(2):390-7. doi: 10.1016/s0015-0282(03)00594-6.
Zotero 插件